Advertisement

Picture [iito] Männer Ballett 650x80px
Organisation › Details

Atriva Therapeutics GmbH

Atriva Therapeutics, founded in 2015, is a biopharmaceutical company pioneering the development of host-targeting antiviral therapies setup by a team of leading scientists in viral research and seasoned industry experts. The company aims to develop new antiviral therapies against different respiratory viral infections. Atriva’s lead product ATR-002 is a first-in-class host-targeting agent, inhibiting viral replication in influenza and other respiratory infections, an area of high unmet medical need. The Company owns five broad patent families with broad coverage related to the use of MEK inhibitors for anti-viral therapies and late expiry in 2038. Atriva was a winner of the German 2016 Science4Live business plan concept contest. Atriva Therapeutics is located in Tübingen, Germany. *

 

Period Start 2015-05-21 established
  Predecessor University of Tübingen (Eberhard-Karls-Universität)
Products Industry virostatic agent
  Industry 2 ATR-002 (Atriva Therapeutics)
Person Person Lichtenberger, Rainer (Atriva 201606 CEO + Co-Founder before Cevec + Merckle/ratiopharm + Merck KGaA)
     
Region Region Tübingen
  Country Germany
  Street 1 Eisenbahnstr.
  City 72072 Tübingen
  Tel +49-7071-859-7673
    Address record changed: 2020-12-11
     
Basic data Employees n. a.
     
    * Document for �About Section�: Atriva Therapeutics GmbH. (1/3/19). "Press Release: Atriva Therapeutics Announces First Closing of Series A Financing Round". Tübingen.
     
   
Record changed: 2020-12-11

Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Atriva Therapeutics GmbH


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture [iito] No Content Marketing 650x80px




» top